MIOCHOL Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Miochol, and what generic alternatives are available?
Miochol is a drug marketed by Novartis and Bausch And Lomb and is included in two NDAs.
The generic ingredient in MIOCHOL is acetylcholine chloride. There are three drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the acetylcholine chloride profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for MIOCHOL?
- What are the global sales for MIOCHOL?
- What is Average Wholesale Price for MIOCHOL?
Summary for MIOCHOL
US Patents: | 0 |
Applicants: | 2 |
NDAs: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 106 |
Clinical Trials: | 3 |
Patent Applications: | 1,109 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for MIOCHOL |
DailyMed Link: | MIOCHOL at DailyMed |
![MIOCHOL drug patent expirations Drug patent expirations by year for MIOCHOL](/p/graph/s/t/MIOCHOL-patent-expirations.png)
![Drug Prices for MIOCHOL](/p/graph/drug-price/MIOCHOL.png)
Recent Clinical Trials for MIOCHOL
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
University Hospital, Linkoeping | N/A |
University of Pittsburgh | Phase 1 |
Gladwin, Mark, MD | Phase 1 |
US Patents and Regulatory Information for MIOCHOL
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Novartis | MIOCHOL | acetylcholine chloride | FOR SOLUTION;OPHTHALMIC | 016211-001 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Bausch And Lomb | MIOCHOL-E | acetylcholine chloride | FOR SOLUTION;OPHTHALMIC | 020213-001 | Sep 22, 1993 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |